Has the incidence, etiology, evaluation, and management of pediatric catatonia changed over time, especially following the ...
There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback